BlackRock Advisors’s Adamas Pharmaceuticals, Inc. ADMS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | $143K | Buy |
8,489
+180
| +2% | +$3.03K | ﹤0.01% | 2807 |
|
|
2016
Q3 | $136K | Buy |
8,309
+774
| +10% | +$12.7K | ﹤0.01% | 2818 |
|
|
2016
Q2 | $114K | Sell |
7,535
-30,985
| -80% | -$469K | ﹤0.01% | 2851 |
|
|
2016
Q1 | $557K | Buy |
38,520
+2,731
| +8% | +$39.5K | ﹤0.01% | 1980 |
|
|
2015
Q4 | $1.01M | Sell |
35,789
-9,148
| -20% | -$259K | ﹤0.01% | 1676 |
|
|
2015
Q3 | $752K | Sell |
44,937
-4,570
| -9% | -$76.5K | ﹤0.01% | 1877 |
|
|
2015
Q2 | $1.3M | Buy |
49,507
+2,332
| +5% | +$61.1K | ﹤0.01% | 1456 |
|
|
2015
Q1 | $825K | Buy |
47,175
+46,002
| +3,922% | +$804K | ﹤0.01% | 1656 |
|
|
2014
Q4 | $20K | Sell |
1,173
-96,300
| -99% | -$1.64M | ﹤0.01% | 3461 |
|
|
2014
Q3 | $1.82M | Sell |
97,473
-9,200
| -9% | -$171K | ﹤0.01% | 1175 |
|
|
2014
Q2 | $1.95M | Buy |
+106,673
| New | +$1.95M | ﹤0.01% | 1158 |
|